Patents/Assignees

Kinase Pharma Inc.

3 patents in portfolio

US12325864utility2025
Recombinant Virus Vector (RVV) for Inhibiting Epidermal Growth Factor Receptor (EGFR) Activity and Method of Making an Agent/target Cell Complex to Increase Cetuximab-like Protein (CLP) Production
0 cites
US11793889utility2023
Methods for Selective Kinase Inhibition by Endogenously Produced Antagonists of One or More Kinases
0 cites
US11603541utility2023
Compositions and Method of Making a Complex Able to Increase Production of a Cetuximab-like Protein (CLP) in a Target Cell
0 cites